Venous Thromboembolic Disease Clinical Trials

7 recruiting

Venous Thromboembolic Disease Trials at a Glance

7 actively recruiting trials for venous thromboembolic disease are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Dijon, Rouen, and Clermont-Ferrand. Lead sponsors running venous thromboembolic disease studies include Centre Hospitalier Universitaire de Saint Etienne, China-Japan Friendship Hospital, and Centre Hospitalier Universitaire Dijon.

Browse venous thromboembolic disease trials by phase

Treatments under study

About Venous Thromboembolic Disease Clinical Trials

Looking for clinical trials for Venous Thromboembolic Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Venous Thromboembolic Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Venous Thromboembolic Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk100 enrolled1 locationNCT07270263
Recruiting
Phase 2

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

Venous Thromboembolic DiseaseAutoimmune Hemolytic AnemiaProlonged Anticoagulation
Centre Hospitalier Universitaire Dijon72 enrolled1 locationNCT05089227
Recruiting
Not Applicable

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Deep Venous ThrombosisVenous ThromboembolismPulmonary Embolism+2 more
China-Japan Friendship Hospital5,800 enrolled1 locationNCT04211181
Recruiting

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Venous Thromboembolic Disease
University Hospital, Rouen2,000 enrolled1 locationNCT07016542
Recruiting

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

Venous Thromboembolic Disease
University Hospital, Brest2,640 enrolled8 locationsNCT03206372
Recruiting
Phase 3

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Venous Thromboembolic Disease
Centre Hospitalier Universitaire de Saint Etienne1,400 enrolled28 locationsNCT05627375
Recruiting
Not Applicable

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Venous Thromboembolic DiseaseDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Scott C. Woller, MD152,000 enrolled1 locationNCT06232551